Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Enright, US
Christopher Milner Enright, Ladera Ranch, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120055344 | BREW BASKET WITH SPLASH RESERVOIR - A brew basket for a brewing apparatus includes a splash protection structure to protect against spilling when the brew basket is removed prematurely with hot brewing liquid therein. The structure is a splash reservoir formed near the handle of the brew basket, extending the interior surface of the brew basket radially outward at the site of the compartment where the basket is pulled out of the brewing apparatus. A well or reservoir attenuates a wave of liquid created by pulling the basket out by directing the wave to the reservoir rather than impact the side wall of the basket, where hot liquid would then tend to splash or spill out. | 03-08-2012 |
Frederick M. Enright, Baton Rouge, LA US
| Patent application number | Description | Published |
|---|---|---|
| 20090047235 | Paratransgenesis to Control Termites or Other Social Insects - A paratransgenesis system is disclosed to kill targeted social insects such as termites and cockroaches, for example the Formosan subterranean termite. A genetically modified yeast can be effectively used to express and deliver lytic peptides directly within the termite gut. Some highly lytic peptides directly damage the insect gut itself, leading to the death of the insect within about three days. Other lytic peptides kill all (or at least most) species of protozoa in the termite gut. The protozoa provide wood-digesting enzymes (cellulases) to the termite. Without these protozoa (and their cellulases) the insect dies within about six weeks. The system is completely free from conventional neurotoxins and other organic pesticides. | 02-19-2009 |
| 20100016227 | LIGAND/LYTIC PEPTIDE COMPOSITIONS AND METHODS OF USE - Amphipathic lytic peptides are ideally suited to use in a ligand/cytotoxin combination to specifically inhibit cells that are driven by or are dependent upon a specific ligand interaction; for example, to induce sterility or long-term contraception, or to attack tumor cells, or to selectively lyse virally-infected cells, or to attack lymphocytes responsible for autoimmune diseases. The peptides act directly on cell membranes, and need not be internalized. Administering a combination of gonadotropin-releasing hormone (GnRH) (or a GnRH agonist) and a membrane-active lytic peptide produces long-term contraception or sterilization in animals in vivo. Administering in vivo a combination of a ligand and a membrane-active lytic peptide kills cells with a receptor for the ligand. The compounds are relatively small, and are not antigenic. Lysis of gonadotropes has been observed to be very rapid (on the order of ten minutes.) Lysis of tumor cells is rapid. The two components—the ligand and the lytic peptide—may optionally be administered as a fusion peptide, or they may be administered separately, with the ligand administered slightly before the lytic peptide, to activate cells with receptors for the ligand, and thereby make those cells susceptible to lysis by the lytic peptide. The compounds may be used in gene therapy to treat malignant or non-malignant tumors, and other diseases caused by clones or populations of “normal” host cells bearing specific receptors (such as lymphocytes), because genes encoding a lytic peptide or encoding a lytic peptide/peptide hormone fusion may readily be inserted into hematopoietic stem cells or myeloid precursor cells. | 01-21-2010 |
| 20100199366 | Gene therapy using transposon-based vectors - Methods and compositions are presented for the administration of transposon based vectors to an animal or human to provide gene therapy to the animal or human. | 08-05-2010 |
| 20110162096 | Gene Therapy Using Transposon-Based Vectors - Methods and compositions are presented for the administration of transposon-based vectors to an animal or human to provide gene therapy to the animal or human | 06-30-2011 |
John J. Enright, Troy, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20090277260 | WHEEL AND BRAKE ASSEMBLY - A wheel and brake assembly ( | 11-12-2009 |
John Joseph Enright, Troy, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20110220763 | TAPERED BRAKE DISK - A brake stack comprises a stator having an annular, inner periphery section disposed substantially along a first radial plane extending normal to an axis of a wheel, and a stator side wall having a first stator contact surface, the first stator contact surface including a sloped portion which deviates away from the radial plane defined by the annular, inner periphery section. The brake stack further comprises a rotor having an annular, outer periphery section disposed substantially along a second radial plane extending normal to the axis of the wheel, and a rotor side wall having a first rotor contact surface shaped complementary to the first stator contact surface, wherein the stator and the rotor are interleaved. | 09-15-2011 |
Kerry Enright, Williston, VT US
| Patent application number | Description | Published |
|---|---|---|
| 20090313181 | SYSTEM AND METHOD FOR INTERNATIONAL PARTNER COLLABORATION - A system and associated method for gathering data necessary for exchanging a product between at least two partners. Each partner in said at least two partners resides in a different country. The method provides for gathering information regarding the product being exchanged and more specifically a delivery location, a returning date and returning location if the product is being returned to said sending partner, a single valuation for said product being exchanged, a lot number for said product, clean-room requirements for said receiving partners, a product history, and a genealogy of said product being exchanged. After collecting the information, the method formats said information according to the specific receiving partner's requirements. The method further determines the appropriate method of transmission according to each receiving partner's requirements. Finally, the method sends each receiving partner their specifically formatted version of the information regarding the product being exchanged. | 12-17-2009 |
Kerry John Enright US
| Patent application number | Description | Published |
|---|---|---|
| 20100268561 | Ten-Level Enterprise Architecture Systems and Tools - This disclosure describes sets of systems and tools that drive complex enterprise execution logic top to bottom, end to end and site to site through the discrete execution and control of ten levels of mission-critical enterprise structure: | 10-21-2010 |
Michael A. Enright, Huntington Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120021764 | System and Method for Robust Navigation and Communication Via A Cooperative Ad-hoc Network - A MANET Signals of Opportunity (SoOP) network providing positioning information to mobile users cooperatively. Mobile nodes access SoOP/GNSS to determine location and share navigation and communication information with other users to extend coverage to adjacent nodes. The system also allows disadvantaged users to determine positioning based upon beacon information transmitted without access to GNSS signals. | 01-26-2012 |
Mitchell Enright, Carlsbad, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100000676 | Skin Substitute Manufacturing Method - An improved skin substitute production method is presented that minimizes destruction of the nylon weave netting that comprises the skin substitute at the pore holes of the skin substitute membrane, The skin substitute is comprised of non-biological materials produced with a series of regularly-spaced pores and a nylon weave netting. The top component is a thin (approximately 0.001″ thick) silicone elastomer in which pore holes have been vacuum-pulled; physically attached to the silicone elastomer is a fine knitted nylon fabric (12/1, 15/1 denier). | 01-07-2010 |
Mitchell K. Enright, Carlsbad, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090232878 | Artificial Skin Substitute - An improved skin substitute is presented comprised of non-biological materials produced with a series of regularly-spaced pores and a nylon weave netting. The top component is a thin (approximately 0.001″ thick) silicone elastomer in which pore holes have been vacuum-pulled; physically attached to the silicone elastomer is a fine knitted nylon fabric (12/1, 15/1 denier); incorporated into the silicone/nylon structure are collagen peptides [about 10 micrograms per square centimeter of Porcine type 1—“the active component”] without cross-linking agent to enable a quick interaction with fibrin in the wound to achieve acute adherence. | 09-17-2009 |
Robert Enright, Brentwood, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100073283 | CONTROLLER WITH USER-SELECTABLE DISCRETE BUTTON EMULATION - A user device with a position control device such as a thumbstick may be used to emulate discrete button presses via user selection of a mode switch on the device. | 03-25-2010 |